WWC
BMY icon

Waypoint Wealth Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Waypoint Wealth Counsel’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$947K Sell
15,620
-6,514
-29% -$380K 0.49% 33
2025
Q4 		$1.19M Buy
+22,134
New +$1.06M 0.44% 40

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waypoint Wealth Counsel's BMY Position: Q1 2026 in Review

Waypoint Wealth Counsel reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q1 2026, selling an estimated $380K and leaving 15,620 shares worth $947K. The position accounts for 0.49% of the portfolio, ranked #33.

Waypoint Wealth Counsel first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.19M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Waypoint Wealth Counsel held 15,620 shares of Bristol-Myers Squibb worth $947K as of Q1 2026.
  • Waypoint Wealth Counsel sold 6,514 Bristol-Myers Squibb shares in Q1 2026, an estimated $380K.
  • Bristol-Myers Squibb made up 0.49% of Waypoint Wealth Counsel's portfolio in Q1 2026, its #33 holding.
  • Waypoint Wealth Counsel first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • Waypoint Wealth Counsel's Bristol-Myers Squibb position peaked at $1.19M in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Waypoint Wealth Counsel's 13F filing for Q1 2026, filed 23 Apr 2026.